Compare Alphatec Holdings, Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
USD 2,530 Million (Small Cap)
NA (Loss Making)
NA
0.00%
11.69
-325.84%
72.06
Revenue and Profits:
Net Sales:
197 Million
(Quarterly Results - Sep 2025)
Net Profit:
-29 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-29.16%
0%
-29.16%
6 Months
-9.08%
0%
-9.08%
1 Year
21.02%
0%
21.02%
2 Years
-16.75%
0%
-16.75%
3 Years
5.98%
0%
5.98%
4 Years
38.76%
0%
38.76%
5 Years
-13.46%
0%
-13.46%
Alphatec Holdings, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
41.26%
EBIT Growth (5y)
-175.21%
EBIT to Interest (avg)
-10.78
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-6.44
Sales to Capital Employed (avg)
1.01
Tax Ratio
0.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
84.57%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-30.22
EV to EBIT
-19.64
EV to EBITDA
-72.82
EV to Capital Employed
6.74
EV to Sales
3.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-34.32%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 59 Schemes (23.76%)
Foreign Institutions
Held by 87 Foreign Institutions (11.07%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
196.50
150.70
30.39%
Operating Profit (PBDIT) excl Other Income
11.00
-8.80
225.00%
Interest
12.90
6.60
95.45%
Exceptional Items
-6.50
-3.00
-116.67%
Consolidate Net Profit
-28.60
-39.60
27.78%
Operating Profit Margin (Excl OI)
-47.90%
-203.50%
15.56%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 30.39% vs 27.39% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 27.78% vs 7.26% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
611.60
482.30
26.81%
Operating Profit (PBDIT) excl Other Income
-39.60
-88.60
55.30%
Interest
24.90
16.60
50.00%
Exceptional Items
-13.30
-25.10
47.01%
Consolidate Net Profit
-162.10
-186.60
13.13%
Operating Profit Margin (Excl OI)
-201.00%
-307.50%
10.65%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 26.81% vs 37.45% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 13.13% vs -23.33% in Dec 2023
About Alphatec Holdings, Inc. 
Alphatec Holdings, Inc.
Pharmaceuticals & Biotechnology
Alphatec Holdings, Inc. is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. Its products include Cervical and Cervico-Thoracic Products, which include Trestle Luxe Anterior Cervical Plate System and Pegasus Anchored Cervical Interbody; Thoracolumbar Fixation Products, which include Arsenal Degenerative System and OsseoScrew Spinal Fixation System; Spinal Spacers, which include Battalion Universal Spacer System and Alphatec Solus Locking ALIF Spinal Spacer; minimally invasive surgery Products, which include Illico Minimally Invasive Surgery System and BridgePoint Spinous Process Fixation System, and Biologics, which include Neocore Osteoconductive Matrix.
Company Coordinates 
Company Details
5818 El Camino Real , CARLSBAD CA : 92008
Registrar Details






